The recently proposed adaptor protein 4 (AP-4) deficiency syndrome comprises a group of congenital neurological disorders characterized by severe intellectual disability (ID), delayed or absent speech, hereditary spastic paraplegia, and growth retardation. AP-4 is a heterotetrameric protein complex with important functions in vesicle trafficking. Mutations in genes affecting different subunits of AP-4, including AP4B1, AP4E1, AP4S1, and AP4M1, have been reported in patients with the AP-4 deficiency phenotype. We describe two siblings from a non-consanguineous couple who presented with severe ID, absent speech, microcephaly, growth retardation, and progressive spastic tetraplegia. Whole-exome sequencing in the two patients identified the novel homozygous 2-bp deletion c.1160_1161delCA (p.(Thr387Argfs*30)) in AP4B1. Sanger sequencing confirmed the mutation in the siblings and revealed it in the heterozygous state in both parents. The AP4B1-associated phenotype has previously been assigned to spastic paraplegia-47. Identification of a novel AP4B1 alteration in two patients with clinical manifestations highly similar to other individuals with mutations affecting one of the four AP-4 subunits further supports the observation that loss of AP-4 assembly or functionality underlies the common clinical features in these patients and underscores the existence of the clinically recognizable AP-4 deficiency syndrome.
INTRODUCTION
A group of congenital neurological diseases characterized by severe intellectual disability (ID), absence of speech, and early-onset progressive spasticity leading to spastic para-or tetraplegia has recently been associated with deficiency of different adaptor protein 4 (AP-4) complex subunits. 1 AP-4 belongs to a family of adaptor proteins consisting of the five heterotetramers AP-1 to AP-5, which have key functions in vesicle trafficking. 2, 3 APs are composed of two large subunits (b1-5, and either a, g, d, e, or z), one medium subunit (m1-5), and one small subunit (s1-5), and these mediate different cellular transport steps. The ubiquitously expressed AP-4 complex is composed of the four subunits AP4B1 (b1), AP4E1 (e1), AP4M1 (m1), and AP4S1 (s1) and has a role in trafficking of proteins from the trans Golgi network to endosomes. 4, 5 Mutations in genes encoding different subunits of the AP-4 complex have been associated with autosomal-recessive ID with spastic paraplegia: A homozygous splice site mutation in AP4M1 was found in family members affected by early infantile hypotonia, delayed psychomotor development, inability to walk independently, absent speech, progressive spasticity, and severe ID (MIM 612936). 6 In two siblings with spastic paraplegia cerebral palsy with profound ID, microcephaly, epilepsy, and white matter loss, a homozygous microdeletion covering part of the AP4E1 gene has been identified (MIM 613744). 7 Abou Jamra et al 1 and Najmabadi et al 8 described homozygous mutations of AP4B1 (MIM 614066), AP4S1 (MIM 614067), AP4E1, and AP4M1 in individuals with severe ID, growth retardation, stereotypic laughter, progressive spasticity, and inability to walk as the core phenotype. Two Arabic siblings with hereditary spastic paraplegia (HSP), ID, and seizures 9 were found to carry the homozygous c.664delC mutation in AP4B1. 10 Thinning of the corpus callosum has been proposed to be a key feature of the AP-4-associated HSP. 6, 7, 10 Identification of a homozygous AP4E1 nonsense mutation in twins with HSP and mycobacterial disease suggests a role of the AP-4 complex not only in the neurological but also in the immunological system. 11 Taken together, the common clinical features in patients with mutations in different subunits of the AP-4 complex indicate that loss of one subunit results in severely impaired complex formation leading to the AP-4 deficiency syndrome. 1, 2 The function of the AP-4 adaptor complex in endosomal trafficking highlights a novel biological mechanism underlying an HSP type associated with severe ID. 12 Here we report a homozygous 2-bp deletion in AP4B1 in two siblings with severe ID, microcephaly, growth retardation, inability to walk, and absent speech, confirming the common phenotype associated with AP-4 deficiency.
SUBJECTS AND METHODS

Case reports
The study was approved by the Ethics Committee of the Medical Chamber of Hamburg (No. PV3802). Written consent was obtained from the parents of patients 1 and 2, including consent to use the photographs in this report.
Patient 1 is a 14-year-old girl ( Figure 1a and Table 1 ) born to nonconsanguineous healthy parents. She was born by natural delivery after medical induction at 41 weeks of gestation; birth weight was 4000 g, length was 52 cm, and occipitofrontal circumference (OFC) was 34 cm. Apgar scores were 10-10-10; there were no perinatal complications. At the age of 3 months, psychomotor developmental delay was noticed. The girl was microcephalic ( À2 s.d.) at the age of 1 year. At 18 months of age, she began to speak a few words. The propositus started to walk at the age of 20 months. At the age of 3.5 years, the patient was admitted to hospital because of duplicated ureter, urosepsis, pelvic duplex, and febrile seizure. Three years later she experienced another episode of febrile seizure, which was controlled by antiepileptic treatment. The patient was referred to one of us (ES) when she was almost 4 years old. She could walk only short distances and spoke short sentences. Microcephaly ( À2 s.d.) and increased tonus of lower limbs were observed. Recent clinical examination at the age of 14 years revealed microcephaly ( À2 s.d.), short stature ( À2 s.d.), club foot, skin hyperpigmentation on the lumbar region, and low anterior and posterior hairline. The patient had spastic tetraplegia with contractures, particularly of the lower limbs, hyperreflexia, and positive Babinski sign; she had been wheelchair-bound since the age of 12 years. Pelvis X-ray revealed valgosity of the hips with bilateral subluxation and acetabular dysplasia. Otologic and ophthalmologic evaluations were normal, similar to conventional and molecular karyotyping as well as biochemical serum and urine tests. She had facial dysmorphism with tongue protrusion, open mouth, widely spaced teeth, gingival hyperplasia, prominent supraorbital ridges, and a broad nasal root. The patient had a shy and anxious character and had been communicating nonverbally since the age of 13 years; she never had stereotypic laughter. She was able to control urinary and anal sphincters and eat without assistance. Electroencephalography (EEG) evaluations revealed a generalized abnormality with a low-frequency brain activity, especially in the centroparietal region. Brain magnetic resonance imaging (MRI) did not show any abnormality.
Patient 2 ( Figure 1b and Table 1 ) is the 12-year-old brother of patient 1. Birth was by cesarean section at 41 weeks of gestation because of suspected fetal stress. However, postpartal adaptation was normal with Apgar scores 9-10-10. Birth weight was 3500 g, length was 50 cm, and OFC was 34 cm. Apathetic behaviour was noticed at the age of 3 months. His psychomotor development was delayed: he could walk at the age of 18 months, spoke his first words at the age of 24 months, and had a very short attention span. Physical examination at the age of 2 years showed microcephaly and psychomotor developmental delay. Mild spasticity of lower extremities was noticed with hyperreflexia and Babinski sign. He was able to walk until the age of 7.5 years, after which he could walk only with assistance and had been wheelchair-dependent since the age of 12. At the age of 10 years, the Achilles tendon on the right side was operated upon because of club foot. Shortly after, febrile convulsions occurred, which led to antiepileptic therapy. X-ray investigation of the hips revealed coxa valga with acetabular dysplasia. Facial dysmorphism was noted with large auricles, synophrys, open mouth, tongue protrusion, prominent nasal root, and mild convergent strabismus. He had a more severe ID than his sister, with very short attention span and inability to communicate. Additional clinical findings were spastic tetraplegia with contractures of the knees, thoracic dextroscoliosis, and lumbar levoscoliosis. He had hyperpigmentation on the right shoulder. He had a shy and anxious character and no history of stereotypic laughter. Latest examination at the age of 12 years revealed mild microcephaly ( À2 s.d.) and short stature ( À2 s.d.) . EEG findings were identical to those of his sister. MRI of the brain revealed mild thinning of the corpus callosum in the dorsal region of the splenium.
Whole exome sequencing (WES) and data analysis
For detailed description of the WES and Sanger sequencing procedures, see Supplementary Methods.
RESULTS
We performed WES on genomic DNA of patients 1 and 2 and on their mother and filtered for compound heterozygous and homozygous sequence variants in the siblings. No compound heterozygous mutation was identified; however, we detected a 2-bp deletion, c.1160_1161delCA, in the AP4B1 gene (RefSeq NM_006594.2) in two patients in the homozygous state (Figure 2 ). Sanger sequencing confirmed the homozygous c.1160_1161delCA mutation in exon 7 of AP4B1 in the siblings, whereas both parents were heterozygous (Figure 2 ). This variant was not found in the databases dbSNP, 1000Genomes, and Exome Variant Server. The AP4B1 variant c.1160_1161delCA identified in this study was submitted to the ClinVar database with the accession number SCV000119895 (http://www.ncbi.nlm.nih.gov/ clinvar/?term ¼ SCV000119895). AP4B1 mutations have already been linked to an autosomal recessive form of ID with spastic paraplegia (spastic paraplegia-47, MIM 614066), which fits well to the phenotype of the siblings. Thus, we concluded that the homozygous frameshift mutation in AP4B1 underlies the neurological disorder in both patients.
DISCUSSION
We performed WES in two siblings with severe ID, microcephaly, growth retardation, inability to walk, and absent speech, and detected the homozygous 2-bp deletion c.1160_1161delCA in the AP4B1 gene. This mutation results in a frameshift and in the introduction of a premature termination codon (p. (Thr387Argfs*30) ). Both parents were heterozygous for the AP4B1 mutation. To date, two other mutations in the AP4B1 gene have been identified in individuals with (Table 1) : the homozygous 3-bp insertion c.487_488insTAT (p.(Glu163Valfs*2) is the correct description of the mutation at the protein level) 1 and the 1-bp deletion c.664delC (p.(Leu222Cysfs*31) is the correct description). 10 Remarkably, the three known sequence-level alterations in AP4B1 are small rearrangements and most likely represent loss-of-function mutations. This is in agreement with drastically reduced Ap4b1 transcript levels in fibroblast cells of a patient with the c.487_488insTAT mutation indicating nonsense-mediated mRNA decay. 1 Thus, loss of one AP-4 subunit results in defective AP-4 complex formation leading to impaired endosomal trafficking, especially in the neuronal system. AP4B1 encodes the b1 subunit of the AP-4 complex, which together with AP-1, AP-2, AP-3, and AP-5 constitutes the adaptor protein family. AP complexes 1-5 are transiently transported onto membranes, where they function as coat proteins to select cargo and shape vesicles. These proteins are ubiquitously expressed in human tissues and have an essential role in vesicle trafficking. 2 Mutations in genes that code for different subunits of adaptor protein complexes have been described in human disorders. Mutations in AP1S1 and AP1S2 encoding s subunits of the AP-1 complex have been found in patients with MEDNIK syndrome (mental retardation, enteropathy, deafness, neuropathy, ichthyosis, keratodermia) and an X-linked ID syndrome, respectively. [13] [14] [15] [16] [17] The autosomal recessive Hermansky-Pudlak syndrome 2, which is characterized by platelet defects and oculocutaneous albinism, is caused by mutations in the AP3B1 gene encoding the b1 subunit of the AP-3 complex. 18 Remarkably, heterozygous missense mutations of AP2S1 substituting arginine 15 underlie the familial hypocalciuric hypercalcaemia type 3. 19 The severe neurological phenotype in patients with mutations affecting components of the AP-4 complex suggests that AP-4 has an important role in human brain development. Indeed, in Ap4b1-deficient mice the somatodendritically localized low-density lipoprotein receptor, AMPA, and d2 glutamate receptors were mislocalized in axons, underscoring a function of the AP-4 complex in polarized sorting of these receptors to the somatodendritic domain of neurons. 20 However, Ap4b1-null mice have an almost normal brain and no neurological defects were seen in this mouse model, 20 indicating important and non-redundant functions of the AP-4 complex in the human brain.
The phenotype of AP4B1-mutation-positive individuals is quite similar (Table 1) . Microcephaly became obvious at the age of 1 year and developed to À2 to À3 s.d. later in life. Where data were available, short stature was present. All individuals had significant psychomotor developmental delay that developed to severe ID; seizures can occur. Five of seven patients could walk independently, and one with assistance. Increased tonus of the lower limbs was noticed between the ages of 2 and 5 years. Spastic para-or tetraplegia with contractures and hyperreflexia was present between the ages of 10 and 14 years. Patients became wheelchair-dependent around the age of 12 years. Marked speech delay or absent speech was noticed in the patients. Brain imaging revealed periventricular white matter changes in two and thinning of the corpus callosum in three individuals; no MRI data were available for three siblings. 1 The phenotype associated with AP4B1 mutations has been assigned the formal hereditary spastic paraplegia type 47 (SPG47) entry. 10, 12 A thin corpus callosum could likely give a clue to SPG47 and has also been observed in patients harbouring mutations in AP4M1 or AP4E1. 6, 7 In summary, the similar clinical features in patients with mutations affecting different AP-4 subunits underscore the existence of the recognizable AP-4 deficiency syndrome. The phenotype is characterized by microcephaly, severe ID with delayed or absent speech, progressive spasticity leading to wheelchair dependence in early adolescence, and growth retardation. Loss of AP-4 complex 
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assembly and functionality in patients with either AP4M1, E1, S1, or B1 mutations is thus the common pathogenetic mechanism underlying the AP-4 deficiency phenotype.
